Related Experiment Video
Updated: Jun 26, 2026
13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
In vitro-targeted gene identification in patients with hepatitis C using a genome-wide microarray technology
Susanne Hagist1, Holger Sültmann, Gunda Millonig
1Department of Internal Medicine, Salem Medical Center, University of Heidelberg, Heidelberg, Germany.
Hepatology (Baltimore, Md.)
|January 30, 2009
Summary
This study identifies genes linked to iron and oxidative stress in liver diseases like hepatitis C (HCV) and hereditary hemochromatosis (HH). An in vitro approach pinpointed candidate genes, including NPPB, offering insights into disease mechanisms.
Area of Science:
- Molecular Biology
- Genomics
- Hepatology
Background:
- Iron overload and reactive oxygen species (ROS) exacerbate liver damage in hereditary hemochromatosis (HH) and chronic hepatitis C (HCV).
- Mechanisms of HCV-induced iron accumulation remain unclear.
- Understanding iron dysregulation is crucial for liver disease progression.
Purpose of the Study:
- To identify genes regulated by ROS and iron in hepatitis C virus (HCV) patients.
- To investigate the role of iron and oxidative stress in liver disease pathogenesis.
- To discover novel candidate genes for HCV and HH.
Main Methods:
- Genome-wide DNA microarray analysis of HepG2 cells under in vitro iron and oxidative stress.
- Identification of ROS/iron-regulated genes using a 32,231 cDNA clone microarray.
- Validation of candidate genes in HCV and HH patient samples via reverse-transcription polymerase chain reaction.
Main Results:
- In vitro challenge identified 265 iron-related and 1326 ROS-related genes in HepG2 cells.
- 233 significantly regulated genes were found in patients with mild (HCV) or severe (HH) iron deposition.
- 17 in vitro-selected genes overlapped with patient genes; NPPB was uniquely iron-regulated and differentially expressed between HCV and HH.
Conclusions:
- High-density microarray combined with in vitro selection is effective for identifying disease-relevant genes.
- This approach can uncover candidate genes for liver diseases like HCV and HH.
- Further research can explore the identified genes, such as NPPB, for diagnostic or therapeutic potential.
Related Concept Videos
02:34DNA Microarrays
Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...